bearish
Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great
454 Views26 Jan 2023 11:46
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (12th Feb 2023) - Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault12 Feb 2023
- Mankind Pharma Pre-IPO - Thoughts on Valuations09 Feb 2023
- Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins08 Feb 2023
- Mankind Pharma Pre-IPO - The Positives - Diverse Portfolio with Steady past Performance25 Jan 2023
- Mankind Pharma Pre-IPO Tearsheet20 Sep 2022
x